FindTrial
Sign In

Preparing the radiation medicine for wound imaging

Standardization of 18F-FDG labelled leukocytes : An in-vitro study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050306
Enrollment
24
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Navaneeth P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: HUMAN VOLUNTEERS FASTING BLOOD SUGAR SHOULD BE LESS THAN 180mg/dl

Exclusion criteria

Exclusion criteria: HUMAN VOLUNTEERS FASTING BLOOD SUGAR SHOULD NOT BE MORE THAN 180mg/dl

Design outcomes

Primary

MeasureTime frame
STANDARDIZATION OF 18F-FDG WBC RADIOPHARMACEUTICAL FOR INFECTION IMAGINGTimepoint: 3 months—

Secondary

MeasureTime frame
LABELLING EFFICIENCY AND CELL VIABILITY 18F-FDG WBC RADIOPHARMACEUTICALS INVITROTimepoint: 3 months—

Countries

India

Contacts

Public ContactNAVANEETH P

Manipal College Of Health Professions

shivanand.b@manipal.edu8277559021

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026